Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
January 29, Lund Aktiedagen
December 11, 2018
Share
News
August 23, 2024
Interim report January – June 2024 for CombiGene AB (publ)
June 25, 2024
Västra Hamnen publishes initial analysis of CombiGene
June 24, 2024
CombiGene enters into a license agreement with Spark for the epilepsy project CG01
June 14, 2024
CombiGene selects Västra Hamnen Corporate Finance as new Certified Adviser
May 27, 2024
CombiGene appoints new Chief Scientific Officer
May 23, 2024
Bulletin from the annual general meeting of CombiGene AB (publ)
May 17, 2024
Interim report January – March 2024 for CombiGene AB (publ)
April 26, 2024
CombiGene AB (publ) publishes annual report for 2023
Load more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this website, we will assume that you accept it.
Ok
Privacy policy
